Silvercrest Asset Management Group LLC Staar Surgical CO Transaction History

Silvercrest Asset Management Group LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$50.45 - $72.82 $1.49 Million - $2.16 Million	29,632 Added 47.94%	91,440 $4.81 Million
Q1 2023 May 15, 2023	BUY	$51.25 - $79.34 $3.17 Million - $4.9 Million	61,808 New	61,808 $3.95 Million
Q2 2021 Aug 16, 2021	SELL	$105.76 - $154.96 $6.18 Million - $9.06 Million	-58,457 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$78.5 - $126.48 $2.07 Million - $3.33 Million	-26,367 Reduced 31.08%	58,457 $6.16 Million
Q4 2020 Feb 16, 2021	SELL	$55.93 - $82.78 $1.86 Million - $2.75 Million	-33,227 Reduced 28.15%	84,824 $6.72 Million
Q3 2020 Nov 16, 2020	SELL	$45.65 - $61.81 $99,380 - $134,560	-2,177 Reduced 1.81%	118,051 $6.68 Million
Q2 2020 Aug 14, 2020	SELL	$29.15 - $61.54 $1.03 Million - $2.18 Million	-35,384 Reduced 22.74%	120,228 $7.4 Million
Q1 2020 May 15, 2020	SELL	$25.01 - $42.4 $482,968 - $818,786	-19,311 Reduced 11.04%	155,612 $5.02 Million
Q4 2019 Feb 14, 2020	SELL	$24.55 - $38.13 $1.52 Million - $2.36 Million	-61,873 Reduced 26.13%	174,923 $6.15 Million
Q3 2019 Nov 14, 2019	BUY	$25.78 - $34.8 $6.1 Million - $8.24 Million	236,796 New	236,796 $6.11 Million

251

47.3M

427K

206K

Ticker STAA
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 48,038,300
Market Cap $1.15B
Description
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...

Get notified when there are updates to the investment portfolio of Silvercrest Asset Management Group LLC, based on Form 13F filings with the SEC.

Stay updated on Silvercrest Asset Management Group LLC with notifications on news.